# Evaluation of the Quality of Life Questionnaire-Bronchiectasis (QOL-B) in Patients With Bronchiectasis

> **NCT00805025** · PHASE2 · COMPLETED · sponsor: **Gilead Sciences** · enrollment: 89 (actual)

## Conditions studied

- Bronchiectasis

## Interventions

- **DRUG:** AZLI

## Key facts

- **NCT ID:** NCT00805025
- **Lead sponsor:** Gilead Sciences
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-12
- **Primary completion:** 2009-10
- **Final completion:** 2009-10
- **Target enrollment:** 89 (ACTUAL)
- **Last updated:** 2014-03-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00805025

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00805025, "Evaluation of the Quality of Life Questionnaire-Bronchiectasis (QOL-B) in Patients With Bronchiectasis". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00805025. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*